1250P Camrelizumab plus apatinib combined with POF in patients with untreated advanced gastric cancer (UAGC): A single-center, open-label, single-arm, phase II trial (SYLT-017).

Subjects

Subjects :

*STOMACH cancer
*APATINIB

Details

Language :

English

ISSN :

09237534

Volume :

33

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

159078151

Full Text :

https://doi.org/10.1016/j.annonc.2022.07.1368